Thyme Care Secures $125 Million in Latest Series A Funding Round

Thyme Care secured $125 million in its latest Series A, adding another data point to the FinTech funding market.

Thyme Care Raises $125 million in Funding

Thyme Care Raises $125M, Valuation Tops $2B. [.] For patients, payers, and the broader digital health industry, Thyme Care's doubled valuation is a reminder that even in a tighter funding environment, investors will still bet big on startups tackling healthcare's most expensive, most fragmented problems.

Investors Behind the Funding

The round was backed by its Series A. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Thyme Care operates in FinTech. Thyme Care's financing adds to recent private-market activity.

Strategic Use of Funds

Over $2 billion.

Looking Ahead

Thyme Care Raises $125M, Valuation Tops $2B

Source reference: original announcement/article.